Annual Document 2010

Annual document for the 2010 financial year in accordance with § 10, paragraph 1 of the German Securities Prospectus Act.

The following overview contains references to the information published in the 2010 financial year in accordance with the provisions referred to in § 10, paragraph 1 of the German Securities Prospectus Act.

In the event that an internet link given here is not accessible or not functioning, we can provide you with the information in printed form free of charge. Please contact our Corporate Communications team.

Financial Reports

DateDocument
02/25/2010Consolidated Financial Statements 2009 of MorphoSys Group (IFRS) (PDF, 1.68 MB)
04/09/2010Financial Statements 2009 of MorphoSys AG (HGB) (PDF, 691 KB)
04/09/2010Annual Report 2009 (PDF, 3.38 MB)
04/27/20103-Months-Report 2010 (PDF, 1.17 MB)
07/28/20106-Months-Report 2010 (PDF, 1.19 MB)
10/29/20109-Months-Report 2010 (PDF, 1.19 MB)

Financial Calendar 2010

DateEvent
02/25/2010YE Press Conference and Analyst Meeting in Frankfurt/Main (Germany) and Publication of Financial Statements 2009
04/27/2010Publication of 3-Months-Report 2010
05/21/2010Ordinary Annual Shareholders’ Meeting 2010 in Munich (Germany)
07/28/2010Publication of 6-Months-Report 2010
10/29/2010Publication of 9-Months-Report 2010

Preliminary Announcement on the Disclosure of Financial Statements

DateEvent
02/19/2010Publication of announcement acc.to §§37 v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution
04/14/2010UPDATE: Publication of announcement acc.to §§37 v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution

Ad Hoc-Releases according to § 15 WpHG

DateEvent
06/27/2010Ad hoc: MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program
10/07/2010Ad hoc: MorphoSys Announces Acquisition of Sloning
10/07/2010Ad hoc correction: MorphoSys Announces Acquisition of Sloning
12/10/2010Ad hoc: MorphoSys Increases Revenues and Operating Profit Guidance for 2010

Publication of Directors’ Dealings pursuant to § 15a WpHG

Date

Name and Function

Transaction Type, Number & Security

Date, Place, Price & Transaction Volume

Dec 15, 2010Dr. Marlies Sproll, CSOSale of 13,431 MorphoSys shares

December 14, 2010

XETRA, EUR 17.26

EUR 231,819.06

Dec 15, 2010Dr. Marlies Sproll, CSOSale of 58,569 MorphoSys shares

December 13, 2010

XETRA, EUR 17.81

EUR 1,043,113.89

Dec 15, 2010Dr. Marlies Sproll, CSOPurchase of 3,000 MorphoSys shares

December 13, 2010

Off-Exchange, EUR 14.71

EUR 44,130.00

Jul 13, 2010Dave Lemus, CFOSale of 7,305 MorphoSys shares

July 09, 2010

XETRA, EUR 15.19

EUR 110,962.95

Jul 13, 2010Dr. Simon Moroney, CEOSale of 108,000 MorphoSys shares

July 08, 2010

Off-Exchange, EUR 14.30

EUR 1,544,400.00

Mar 30, 2010Dr. Arndt Schottelius, CDOPurchase of 500 MorphoSys shares

March 26, 2010

Frankfurt, EUR 16.375
EUR 8,187.50

Jan 28, 2010Dr. Arndt Schottelius, CDOPurchase of 500 MorphoSys shares

January 26, 2010

XETRA, EUR 17.00
EUR 8,500.00

Notifications of Participating Interest (§§ 25 und 26 WpHG)

DateEvent
04/20/2010Massachusetts Mutual Life Insurance

Publications According to Exchange Rules

No announcements in 2010.

Development of Number of Voting Rights and Shares

DateDocument
03/31/2010Voting Rights as of 03/31/2010
07/30/2010Voting Rights as of 07/30/2010
08/31/2010Voting Rights as of 08/31/2010
10/29/2010Voting Rights as of 10/29/2010
12/30/2010Voting Rights as of 12/30/2010

Annual Shareholders’ Meeting 2010

DateDocument
04/09/2010Agenda of Annual Shareholders’ Meeting 2010 (PDF, 47 KB)